Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)

NCT07579429 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT07579429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07579429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)
Lead sponsor
University of Colorado, Denver
Phase
Phase 2
Overall status
Recruiting
Start date
May 20, 2026
Completion date
December 18, 2030
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clonal cytopenia of undetermined significance, myelodysplastic syndrome